Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.
Clinical trial NCT05485519 · UNKNOWN
Trial details
- NCT number
- NCT05485519
- Sponsor
- King Abdullah International Medical Research Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2024-05-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.